• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number S-50-040-120-P6
Device Problems Difficult to Remove (1528); Material Separation (1562); Improper or Incorrect Procedure or Method (2017); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/29/2023
Event Type  malfunction  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.H6: medical device problem code 2017 - failure to follow steps.
 
Event Description
It was reported that the procedure was to treat an 80% stenosed lesion in the moderately calcified right popliteal artery.The lesion was prepped with a 5mm balloon to nominal pressure.A 5.0x40mm supera self-expanding stent system (sds) was advanced without resistance over a command guidewire; however, on deployment the stent did not fully deploy, and the tip broke from the shaft.The entire sds including the partially deployed stent and separated tip was retrieved from the patient by simply pulling the system through the 6f sheath against resistance.The delivery system was removed under fluoroscopy.The procedure was completed at this point.There were no reported adverse patient effects and there was no reported clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported material separation was able to be confirmed.The reported activation failure was unable to be replicated in a testing environment due to the condition of the returned device (stent returned deployed).The reported difficult to remove was unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.Reportedly, the entire sds including the partially deployed stent and separated tip was retrieved from the patient by simply pulling the system through the 6f sheath against resistance.It should be noted that the supera peripheral stent system instructions for use, states: precaution: should unusual resistance be felt at any time during stent system removal, the entire system should be removed together with the introducer sheath or guiding catheter as a single unit.Although it was noted the physician used force in the attempts to remove the compromised device, this was due to the anatomy and/or other devices interacting with the partially deployed stent, therefore the force applied during removal of the device seemed to be a reasonable clinical response to the difficulties.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that the distal sheath of the delivery system was entrapped or bent in the moderately calcified and 80% stenosed anatomy and/or other devices such that the ratchet was unable to properly/fully engage the stent resulting in the reported deployment difficulty/activation failure.Interaction and/or manipulation of the device resulted in the noted device damages (multiple distal sheath bends/kinks, multiple shaft bends) likely contributing to the reported deployment difficulty/activation failure and ultimately resulting in the reported tip separation/noted inner member separation; thus resulting in the reported difficult to remove.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18572684
MDR Text Key333619147
Report Number2024168-2024-01074
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648211737
UDI-Public08717648211737
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/24/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberS-50-040-120-P6
Device Lot Number3062961
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/27/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/29/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
COMMAND GUIDE WIRE
Patient Age78 YR
Patient SexFemale
-
-